TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $145 | -99.9% | 97,000 | 0.0% | 0.23% | +10.1% |
| Q3 2022 | $162,000 | -19.0% | 97,000 | -3.0% | 0.21% | -12.2% |
| Q2 2022 | $200,000 | +13.6% | 100,000 | +49.3% | 0.24% | -14.7% |
| Q1 2022 | $176,000 | -12.4% | 67,000 | -7.6% | 0.28% | +7.3% |
| Q4 2021 | $201,000 | -60.2% | 72,509 | -44.4% | 0.26% | -61.9% |
| Q3 2021 | $505,000 | +94.2% | 130,500 | +226.2% | 0.68% | +89.9% |
| Q2 2021 | $260,000 | +116.7% | 40,000 | +291.3% | 0.36% | +76.4% |
| Q4 2020 | $120,000 | -57.6% | 10,223 | -81.3% | 0.20% | -67.0% |
| Q3 2020 | $283,000 | +15.0% | 54,723 | -56.4% | 0.62% | -7.9% |
| Q2 2020 | $246,000 | +121.6% | 125,401 | +88.9% | 0.67% | +72.2% |
| Q1 2020 | $111,000 | -30.2% | 66,400 | -2.2% | 0.39% | -26.8% |
| Q4 2019 | $159,000 | – | 67,900 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |